Workflow
Earnings estimate revisions
icon
Search documents
Commercial Metals (CMC) is an Incredible Growth Stock: 3 Reasons Why
ZACKS· 2025-10-20 17:46
Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying the right ones involves significant challenges and risks [1] Group 1: Company Overview - Commercial Metals (CMC) is highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] - The company is a manufacturer and recycler of steel and metal products, which is currently positioned for strong growth [3] Group 2: Earnings Growth - Historical EPS growth for Commercial Metals is 0.4%, but projected EPS growth for this year is expected to be 59.1%, significantly surpassing the industry average of 40% [4] Group 3: Asset Utilization - Commercial Metals has an asset utilization ratio (sales-to-total-assets ratio) of 1.13, indicating that the company generates $1.13 in sales for every dollar in assets, compared to the industry average of 0.9 [5] Group 4: Sales Growth - The company's sales are projected to grow by 4.8% this year, while the industry average is stagnant at 0% [6] Group 5: Earnings Estimate Revisions - There is a positive trend in earnings estimate revisions for Commercial Metals, with the current-year earnings estimates increasing by 3.8% over the past month [7] Group 6: Investment Positioning - Commercial Metals has achieved a Growth Score of B and a Zacks Rank 1 due to positive earnings estimate revisions, positioning it well for potential outperformance in the market [9]
Why Alnylam (ALNY) Might be Well Poised for a Surge
ZACKS· 2025-10-20 17:21
Core Insights - Alnylam Pharmaceuticals is experiencing solid improvement in earnings estimates, which may lead to continued stock price momentum [1][2] - Analysts are optimistic about the earnings prospects of Alnylam, driving higher estimates that correlate with stock price movements [2][3] Earnings Estimates - Current-quarter earnings estimate is $1.65 per share, reflecting a year-over-year increase of +430.0% [6] - The Zacks Consensus Estimate for the current quarter has risen by 20.29% over the last 30 days, with two estimates increasing and one decreasing [6] - For the full year, the earnings estimate is $3.81 per share, indicating a significant change of +19,150.0% from the previous year [7] - The consensus estimate for the current year has increased by 8.52% due to two upward revisions and no negative revisions [8] Zacks Rank - Alnylam currently holds a Zacks Rank 2 (Buy), indicating promising estimate revisions and potential for outperformance [9] - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have historically outperformed the S&P 500 [9] Stock Performance - Alnylam's stock has increased by 6.2% over the past four weeks due to strong estimate revisions [10] - There may still be further upside potential in the stock, suggesting it could be a good addition to investment portfolios [10]
All You Need to Know About Materion (MTRN) Rating Upgrade to Strong Buy
ZACKS· 2025-10-20 17:00
Core Viewpoint - Materion (MTRN) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system is effective for individual investors as it focuses on earnings estimate revisions, which are strongly correlated with near-term stock price movements [2][3]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [3]. Business Improvement Indicators - The upgrade in ratings and rising earnings estimates suggest an improvement in Materion's underlying business, which could lead to higher stock prices as investors respond positively [4]. Earnings Estimate Revisions - Materion is projected to earn $5.32 per share for the fiscal year ending December 2025, with no year-over-year change, but the Zacks Consensus Estimate has increased by 10% over the past three months [7]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [6]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions and potential for market-beating returns [8][9].
Pfizer (PFE) Beats Stock Market Upswing: What Investors Need to Know
ZACKS· 2025-10-17 22:45
Core Viewpoint - Pfizer's upcoming earnings report is anticipated to show a significant decline in earnings and revenue compared to the previous year, raising investor interest [2][3]. Group 1: Stock Performance - Pfizer's stock increased by 1.16% to $24.51, outperforming the S&P 500's daily gain of 0.53% [1]. - Over the past month, Pfizer's stock has risen by 0.33%, which is below the Medical sector's gain of 2.87% and the S&P 500's gain of 0.71% [1]. Group 2: Earnings Estimates - Analysts expect Pfizer to report earnings of $0.68 per share on November 4, 2025, reflecting a year-over-year decline of 35.85% [2]. - The Zacks Consensus Estimate for Pfizer's revenue is projected at $16.81 billion, down 5.06% from the previous year [2]. Group 3: Full Year Projections - For the full year, the Zacks Consensus Estimates project earnings of $3.07 per share and revenue of $63.4 billion, indicating changes of -1.29% and -0.36% respectively from the prior year [3]. Group 4: Analyst Revisions and Rankings - Recent changes to analyst estimates for Pfizer are crucial as they reflect short-term business trends, with positive revisions indicating analyst optimism [3][4]. - Pfizer currently holds a Zacks Rank of 3 (Hold), with a 1.87% decline in the Zacks Consensus EPS estimate over the past month [5]. Group 5: Valuation Metrics - Pfizer's Forward P/E ratio is 7.88, significantly lower than the industry average of 14.5, suggesting it is trading at a discount [6]. - The PEG ratio for Pfizer is 0.8, compared to the industry average of 1.59, indicating a favorable valuation relative to expected earnings growth [6]. Group 6: Industry Context - The Large Cap Pharmaceuticals industry, part of the Medical sector, has a Zacks Industry Rank of 94, placing it in the top 39% of over 250 industries [7]. - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7].
After Plunging 18.6% in 4 Weeks, Here's Why the Trend Might Reverse for Marcus (MCS)
ZACKS· 2025-10-17 14:36
Core Viewpoint - Marcus (MCS) has experienced significant selling pressure, resulting in an 18.6% decline over the past four weeks, but analysts anticipate improved earnings in the near future [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 typically indicating that a stock is oversold [2] - MCS has an RSI reading of 28.75, suggesting that the heavy selling may be exhausting itself, indicating a potential for price rebound [5] - Stocks oscillate between overbought and oversold states, and the RSI can help investors identify entry points for potential rebounds [3] Group 2: Fundamental Analysis - There has been a strong consensus among sell-side analysts to raise earnings estimates for MCS, leading to a 7.3% increase in the consensus EPS estimate over the last 30 days [7] - An upward trend in earnings estimate revisions is generally associated with price appreciation in the near term [7] - MCS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a turnaround [8]
What Analyst Projections for Key Metrics Reveal About Crown Castle (CCI) Q3 Earnings
ZACKS· 2025-10-17 14:16
Core Insights - Crown Castle (CCI) is expected to report quarterly earnings of $1.04 per share, a decline of 43.5% year-over-year, with revenues forecasted at $1.05 billion, reflecting a decrease of 36.4% compared to the same period last year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.4% higher over the last 30 days, indicating a collective reevaluation by analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3] Revenue and Gross Margin Estimates - Analysts predict 'Revenues- Services and other' to be $52.25 million, down 11.4% from the prior-year quarter [5] - The average estimate for 'Revenues- Site rental' is $998.97 million, indicating a year-over-year decline of 37.3% [5] - The expected 'Services and other- Gross margin' is $23.77 million, down from $31.00 million in the same quarter last year [6] - The consensus for 'Site rental- Gross margin' is $750.04 million, compared to $1.17 billion reported in the same quarter of the previous year [6] Operational Costs - Estimated 'Depreciation, amortization and accretion' is projected at $185.14 million [7] - 'Costs of operations- Services and other' are expected to be $27.60 million, while 'Costs of operations- Site rental' are forecasted to reach $251.59 million [7] Stock Performance - Over the past month, Crown Castle shares have increased by 5.5%, outperforming the Zacks S&P 500 composite, which saw a change of +0.7% [7] - Crown Castle holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the upcoming period [7]
Countdown to Halliburton (HAL) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-10-17 14:16
Core Insights - Wall Street analysts expect Halliburton (HAL) to report quarterly earnings of $0.50 per share, reflecting a year-over-year decline of 31.5% [1] - Revenues are projected to be $5.39 billion, down 5.3% from the same quarter last year [1] - The consensus EPS estimate has been revised downward by 2.6% over the past 30 days, indicating a collective reassessment by analysts [1] Revenue Projections - Analysts estimate 'Revenues- Drilling and Evaluation' to reach $2.28 billion, a decrease of 4.8% from the prior year [4] - 'Revenues- Completion and Production' is expected to be $3.12 billion, down 5.4% year-over-year [4] - 'Revenues- Latin America' is projected at $960.53 million, indicating an 8.8% decline from the previous year [5] - 'Revenues- Europe/Africa/CIS' is expected to reach $754.30 million, reflecting a year-over-year increase of 4.5% [5] - 'Revenues- North America' is anticipated to be $2.17 billion, down 9.1% from the prior-year quarter [5] - 'Revenues- Middle East/Asia' is projected at $1.51 billion, indicating a year-over-year change of -1.5% [6] Operating Income Estimates - 'Operating income- Completion and Production' is expected to be $448.97 million, compared to $669.00 million from the previous year [6] - 'Operating income- Drilling and Evaluation' is projected to reach $337.72 million, down from $406.00 million year-over-year [6] Stock Performance - Over the past month, Halliburton shares have recorded a return of -2.4%, while the Zacks S&P 500 composite has seen a +0.7% change [7] - Halliburton holds a Zacks Rank 5 (Strong Sell), suggesting it may underperform the overall market in the near term [7]
Schlumberger (SLB) Q3 Earnings Top Estimates
ZACKS· 2025-10-17 13:01
Core Insights - Schlumberger reported quarterly earnings of $0.69 per share, exceeding the Zacks Consensus Estimate of $0.66 per share, but down from $0.89 per share a year ago, indicating an earnings surprise of +4.55% [1] - The company posted revenues of $8.93 billion for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.02% and down from $9.16 billion year-over-year [2] - Schlumberger shares have underperformed the market, losing about 14.1% since the beginning of the year compared to the S&P 500's gain of 12.7% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.74 on revenues of $9.51 billion, and for the current fiscal year, it is $2.86 on revenues of $35.46 billion [7] Industry Context - The Oil and Gas - Field Services industry, to which Schlumberger belongs, is currently ranked in the bottom 28% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment [5]
McEwen (MUX) Moves 5.6% Higher: Will This Strength Last?
ZACKS· 2025-10-17 11:21
Company Overview - McEwen Mining (MUX) shares increased by 5.6% to close at $22.72, with a notable trading volume compared to typical sessions, and a total gain of 59.3% over the past four weeks [1][2] Acquisition Announcement - McEwen announced an agreement to acquire Canadian Gold Corp, which owns the Tartan Lake Gold Mine Project in Manitoba, Canada, a high-grade gold project with existing infrastructure and exploration potential [2][3] - The acquisition terms stipulate that each holder of a Canadian Gold share will receive 0.0225 McEwen common shares, equating to a current offer price of CDN $0.60 per Canadian Gold share, with completion expected in early January 2026, pending regulatory approvals [3] Earnings Expectations - McEwen is projected to report quarterly earnings of $0.31 per share, reflecting an 875% year-over-year increase, with revenues expected to reach $66.1 million, a 26.5% increase from the previous year [4] - The consensus EPS estimate for McEwen has been revised 95.2% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [5] Industry Context - McEwen holds a Zacks Rank of 2 (Buy) within the Mining - Miscellaneous industry, which includes other companies like Metalla Royalty & Streaming Ltd. that has also shown significant returns [6]
Hut 8 (HUT) Surges 7.9%: Is This an Indication of Further Gains?
ZACKS· 2025-10-16 19:21
Core Insights - Hut 8 shares increased by 7.9% to close at $53.91, with a notable 42.6% gain over the past four weeks, supported by strong trading volume [1][2] Company Overview - Hut 8's growth is attributed to its vertically integrated, power-first platform that combines energy assets, digital infrastructure, and compute capabilities, particularly for Bitcoin mining and high-performance computing (HPC) [2] - The company employs an experienced team focused on strategic site selection and efficient capital deployment, providing a competitive advantage over traditional data center models [2] Infrastructure and Innovation - Hut 8's infrastructure strategy emphasizes rapid deployment of customized, low-cost facilities, exemplified by the Salt Creek project at $0.3 million per MW, facilitating quick monetization of energy assets [3] - The design of data centers supports both ASIC and GPU compute, ensuring adaptability to emerging technologies [3] - Proprietary software, such as Reactor, optimizes real-time energy usage, reducing costs and enhancing operational efficiency [3] Financial Performance Expectations - The company is projected to report a quarterly loss of $0.16 per share, reflecting a year-over-year increase of 30.4%, with expected revenues of $58.1 million, up 32.8% from the previous year [4] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [5] Industry Context - Hut 8 is categorized under the Zacks Financial - Miscellaneous Services industry, with a current Zacks Rank of 3 (Hold) [6] - In comparison, Qfin Holdings Inc. has seen a -9% change in its EPS estimate over the past month, with a Zacks Rank of 5 (Strong Sell) [7]